Home LiteratureArticle Details
PMID: 9462817 Published · ppublish English Journal Article Review

Avoidable cancers in the Nordic countries. Aims and background.

APMIS. Supplementum ·Vol. 76 ·1997-00-00 ·Pages 1-8

Olsen JH

Abstract

In 1989, an action plan was adopted by the Nordic Council of Ministers with the aim of reducing cancer mortality in the Nordic countries by 15% around the year 2000. This was to be achieved by removing the causes of cancer, by the early diagnosis of cancer and by improving cancer treatment. The results so far have been disappointing. As the causes of many cancers have been identified over the past 40-50 years, the most efficient way of reducing cancer mortality on the basis of current knowledge would be to reduce the prevalence of exposure of the population to cancer-causing agents. Such preventive measures take time to implement, however; furthermore, since the process of carcinogenesis entails a lag period that varies from several years to decades, a decrease in cancer mortality will not be immediately evident. We review here the methodological background for estimating the numbers and proportions of cancers in the Nordic countries that could be avoided through primary prevention.

MeSH Terms
Denmark/epidemiology Finland/epidemiology Humans Iceland/epidemiology Neoplasms/epidemiology,prevention & control Norway/epidemiology Registries/statistics & numerical data Sweden/epidemiology
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Olsen J H
Institute of Cancer Epidemiology, Danish Cancer Society.
Article Info
Journal
APMIS. Supplementum
Abbr.
APMIS Suppl
ISSN
0903-465X
Published
1997-00-00
Pages
1-8
Language
English
Region
Denmark
NLM ID
8812090
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com